Early neural shift detection using functional magnetic resonance imaging: a pilot study with Parkinson’s disease patients undergoing istradefylline and hybrid assistive limb interventions - Report - MDSpire

Early neural shift detection using functional magnetic resonance imaging: a pilot study with Parkinson’s disease patients undergoing istradefylline and hybrid assistive limb interventions

  • By

  • Ken-ichi Tabei

  • Keita Matsuura

  • Naoko Nakamura

  • Hiroyuki Kajikawa

  • Hidekazu Tomimoto

  • Akihiro Shindo

  • May 15, 2026

Share

Clinical Report: Detection of Early Neural Shifts in Parkinson’s Disease

Overview

This preliminary investigation assessed the effects of istradefylline and Hybrid Assistive Limb therapy on brain activation in Parkinson’s disease patients. While fMRI indicated increased neural activation following istradefylline treatment, no significant clinical improvements were observed.

Background

Parkinson's disease (PD) is a neurodegenerative disorder that affects motor and cognitive functions, necessitating effective assessment methods for treatment efficacy. Traditional evaluations often require extended observation periods, which may overlook subtle changes. The integration of pharmacological and non-pharmacological therapies, such as istradefylline and HAL, highlights the need for sensitive biomarkers to detect early functional improvements.

Data Highlights

Rephrase to emphasize the contrast between fMRI results and clinical assessments.

Key Findings

  • Six PD patients participated in the study, receiving either istradefylline or HAL therapy.
  • fMRI results showed increased activation in brain areas related to motor and cognitive functions after istradefylline treatment.
  • No notable enhancements were recorded in clinical assessments for either treatment group.
  • Functional MRI may serve as a more sensitive biomarker for early neural changes compared to traditional clinical evaluations.
  • The study highlights the exploratory nature of assessing immediate functional impacts of new therapies in PD.

Clinical Implications

The findings suggest that fMRI could be a valuable tool for detecting early neural changes in PD, potentially guiding treatment decisions. However, clinicians should remain cautious due to the small sample size and exploratory nature of the study.

Conclusion

Reiterate the importance of cautious interpretation of results due to small sample size.

Related Resources & Content

  1. Hauser RA et al., 2021 -- Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials
  2. Wu D et al., 2025 -- Effect of robot-assisted rehabilitation of patients with Parkinson’s disease: A meta-analysis
  3. Update on treatments for Parkinson's disease motor fluctuations: an international Parkinson and movement disorder society evidence‐based medicine review
  4. Bilateral Double Beta Oscillations Observed in a Parkinson's Disease Patient with Subthalamic Nucleus Electrodes
  5. Longitudinal Alterations in Cerebral Compensation Influence the Progression of Parkinson's Disease
  6. Multimodal brain network topology and enhanced computer-aided diagnosis in Parkinson’s Disease: a systematic review and meta-analysis
  7. Acta Neuropathologica — Structural Adaptations in the Motor Cortex and White Matter Associated with Parkinson’s Disease
  8. International Parkinson and Movement Disorder Society’s 2025 evidence-based medicine update
  9. Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials - Robert A. Hauser, Nobutaka Hattori, Hubert Fernandez, Stuart H. Isaacson, Hideki Mochizuki, Olivier Rascol, Fabrizio Stocchi, June Li, Akihisa Mori, Yu Nakajima, Robert Ristuccia, Peter LeWitt, 2021
  10. Effect of robot-assisted rehabilitation of patients with Parkinson’s disease: A meta-analysis - Dongyun Wu, Zifen Yang, Songchun Liu, Shuqin Guan, Xiaoyong Liu, Jingjing Luo, 2025

Original Source(s)

Related Content